ClinicalTrials.Veeva

Menu

EtCO2 Monitoring in Acute Self-poisoning (CAPNOTOX)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

Acute Intentional Overdose

Study type

Observational

Funder types

Other

Identifiers

NCT01800123
2011-14

Details and patient eligibility

About

There is no consensus on monitoring criteria in acute self poisoning. Clinical scores, vital signs or lactatemia have failed to prove good predictive value.

The main acute self poisoning complication is decreased consciousness level with consequent increased risk of hypoxemia and aspiration pneumonitis.

Several clinical studies have recently shown that EtCO2 monitoring can be valuable in procedural sedation in the emergency department. It is able to predict hypoxemia before any SaO2 decrease and any complications related to these procedures.

We therefore hypothesized that EtCO2 could help in acute self poisoning patients' monitoring in the ED.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >18y/o
  • acute self poisoning patients
  • patients requiring monitoring according to physician's opinion
  • patients not requiring invasive ventilation at ED admission

Exclusion criteria

  • Pregnant woman
  • patients deprived of liberty

Trial design

200 participants in 1 patient group

Acute poisoning
Description:
Consecutive acute drug self poisoned patients admitted in the ED.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems